Cargando…
Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies
Effective treatment strategies for severe coronavirus disease (COVID-19) remain scarce. Hydrolysis of membrane-embedded, inert sphingomyelin by stress responsive sphingomyelinases is a hallmark of adaptive responses and cellular repair. As demonstrated in experimental and observational clinical stud...
Autores principales: | Abusukhun, Murad, Winkler, Martin S., Pöhlmann, Stefan, Moerer, Onnen, Meissner, Konrad, Tampe, Björn, Hofmann-Winkler, Heike, Bauer, Michael, Gräler, Markus H., Claus, Ralf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721106/ https://www.ncbi.nlm.nih.gov/pubmed/34987511 http://dx.doi.org/10.3389/fimmu.2021.784989 |
Ejemplares similares
-
Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection
por: Winkler, Martin Sebastian, et al.
Publicado: (2021) -
Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study
por: Tampe, Désirée, et al.
Publicado: (2021) -
Case Report: Interferon- γ Rescues Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) Function in a COVID-19 Patient With ARDS and Superinfection With Multiple MDR 4MRGN Bacterial Strains
por: Grimm, Clemens, et al.
Publicado: (2021) -
Acid Sphingomyelinase Inhibition Stabilizes Hepatic Ceramide Content and Improves Hepatic Biotransformation Capacity in a Murine Model of Polymicrobial Sepsis
por: Chung, Ha-Yeun, et al.
Publicado: (2018) -
Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome
por: Dickel, Steffen, et al.
Publicado: (2021)